Press release
Eye Melanoma Industry Report 2025-2034: Market Dynamics, Trends, And Forecasts
Eye Melanoma
What Is the Expected Eye Melanoma Market Size During the Forecast Period?
Due to factors such as rising awareness and early detection, older population and exposure to sunlight, increased occurrence of skin cancer, the development of tailored therapies and support or advocacy programs for patients, the eye melanoma market has experienced significant growth in recent years. The market, valued at $9.1 billion in 2024, is projected to increase to $9.89 billion by 2025 at a compound annual growth rate (CAGR) of 8.7%.
The market size for eye melanoma is predicted to experience robust expansion in the upcoming years, with an estimated reach of $13.77 billion in 2029 and a compound annual growth rate (CAGR) of 8.6%. The growth anticipated in this forecast period is credited to ongoing public health projects, research into genetic and molecular profiling, as well as the worldwide trend of an aging population. Prominent trends for the forecast period are the integration of artificial intelligence (AI), the rise of targeted therapies, emphasis on rare disease medication development, patient-oriented drug approval procedures, progress in diagnostic imaging, treatment modality advancements, and imaging technological innovations.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13109
What Are the High-Growth Segments in the Eye Melanoma Market?
The eye melanoma market covered in this report is segmented -
1) By Site: Uvea, Sclera, Retina
2) By Diagnosis: Imaging, Biopsy, Eye Exam
3) By Treatment: Surgery, Radiation Therapy, Targeted Therapy, Immunotherapy, Other Treatment
4) By End User: Hospitals And Clinics, Academic Institutes
Subsegments:
1) By Uvea: Choroid Melanoma, Ciliary Body Melanoma, Iris Melanoma
2) By Sclera: Scleral Melanoma
3) By Retina: Retinal Melanoma
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13109&type=smp
What Key Drivers Are Expected to Influence Future Eye Melanoma Market Growth?
The rise in incidences of eye cancer is anticipated to fuel the expansion of the eye melanoma market. Eye cancer constitutes the abnormal, unregulated cell proliferation in the anatomical structures of the eye. The improved diagnosis of initial-stage cases and their efficient treatment strategies are giving rise to a greater demand for unique therapies and interventions. This increase is powered by advances in detection techniques, heightened knowledge, and improvements in therapy options. For example, the American Cancer Society, a nonprofit group advocating against cancer based in the U.S, stated in January 2023 that the count of eye cancer and orbital cancer cases rose to 3,490 in 2023, an increase of 5.12% from 3,320 in 2021. As such, the escalating prevalence of eye cancer will spur the expansion of the eye melanoma market. Eye Melanoma Market Driver: Escalating Elderly Population Fostering Expansion of the Eye Melanoma Market
Which Companies Hold the Largest Share Across Different Eye Melanoma Market Segments?
Major companies operating in the eye melanoma market report are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Sanofi S.A., GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Koninklijke Philips N.V., Carl Zeiss AG, Genentech Inc., Elekta Instrument AB, Brainlab AG, Optos Plc, Castle Biosciences Inc., Heidelberg Engineering, Nektar Therapeutics, RaySearch Laboratories AB, Nidek Co. Ltd., IDEAYA Biosciences, Immunocore Limited, Topcon Healthcare, Oraya Therapeutics Inc., Delcath Systems Inc.
What Trends Are Driving Growth in The Eye Melanoma Market?
In an effort to improve patient prognosis and quality of life, top firms in the eye melanoma treatment industry are placing their focus on the creation of novel and specific treatments like immunotherapies and targeted therapies. Such treatment methods are relatively new entrants in the realm of oncology. For instance, in January 2022, Immunocore Ltd., a UK-based company specializing in the research and production of biological medication using soluble T-cell receptor technology, garnered approval from the U.S. Food and Drug Administration (FDA) for their product Kimmtrak (tebentafusp-tabn). This T-cell receptor therapeutic marked a groundbreaking development as the first treatment option for patients with non-resectable or metastatic uveal melanoma (mUM). By targeting a specific protein known as gp100, found on the surface of uveal melanoma (UM) cells, Kimmtrak acts as an immunotherapy. It stimulates the patient's immune system to eradicate melanoma by triggering specialized immune cells through designed T-cell receptors, providing a meticulously targeted approach to combating cancer.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/eye-melanoma-global-market-report
What Are the Emerging Geographies for The Eye Melanoma Market Growth?
North America was the largest region in the eye melanoma market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the eye melanoma market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Eye Melanoma Market?
2. What is the CAGR expected in the Eye Melanoma Market?
3. What Are the Key Innovations Transforming the Eye Melanoma Industry?
4. Which Region Is Leading the Eye Melanoma Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Eye Melanoma Industry Report 2025-2034: Market Dynamics, Trends, And Forecasts here
News-ID: 4025268 • Views: …
More Releases from The Business Research Company
Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Seed Treatment Fungicides Market Outlook: How is the Market Expected to Grow by 2025?
Over the past few years, the market for seed treatment fungicides has seen robust growth. Its market value is projected to rise from $2.07 billion in 2024 to $2.21 billion in 2025, signifying a compound annual…
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billio …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Rheology Modifiers Industry?
There has been a consistent expansion in the size of the rheology modifiers market in the past few years. The market, which was worth $8.59 billion in 2024, is projected to increase to $8.89 billion in 2025, demonstrating a compound…
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analys …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Polyurethane Foam Market Outlook: How is the Market Expected to Grow by 2025?
In recent years, the size of the polyurethane foam market has experienced substantial growth. It is projected to increase from a value of $54.27 billion in 2024 to $57.26 billion in 2025, indicating a compound annual growth…
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growt …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Pharmaceutical Intermediates Industry?
There has been consistent growth in the market size of pharmaceutical intermediates over the past few years. The market is predicted to increase from a value of $33.37 billion in 2024, up to $34.95 billion in 2025, with a compound…
More Releases for Melanoma
Rising Incidence Of Melanoma Cases Boosts Metastatic Melanoma Therapeutics Marke …
The Metastatic Melanoma Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Metastatic Melanoma Therapeutics Market Size During the Forecast Period?
The market size for therapeutics in metastatic melanoma has swiftly increased in the past few years. It is projected to augment…
Rising Incidence Of Melanoma Cases Boosts Metastatic Melanoma Therapeutics Marke …
What combination of drivers is leading to accelerated growth in the metastatic melanoma therapeutics market?
The growth of the metastatic melanoma therapeutics market is anticipated to be fueled by the increasing prevalence of melanoma cases. Melanoma, a type of skin cancer, originates in the cells, known as melanocytes, that determine the skin's pigment. Melanomas can develop on any part of the skin. Metastatic melanoma therapeutics comprise various treatments designed to interrupt…
Key Influencer in the Melanoma Therapeutics Market 2025: Surge In Melanoma Incid …
How Are the key drivers contributing to the expansion of the melanoma therapeutics market?
The rise in melanoma cases is predicted to fuel the expansion of the melanoma therapeutics market. Melanoma, a type of skin cancer, begins in the melanocytes. The therapies and medications used to treat melanoma patients and mitigate the effects of cancer are known as melanoma therapeutics. An increase in melanoma cases, therefore, leads to a surge in…
Skin Cancer Market By Cancer Type (Melanoma, Non-melanoma)
Most skin cancers are locally destructive malignant growth of the skin. They come from the epidermis cells, the skin's superficial layer. The vast majority of these types of skin cancers seldom spread (metastasize) to other areas of the body and become life-threatening, unlike cutaneous malignant melanoma.
Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00018117/?utm_source=OpenPR&utm_medium=10379
Key Players Analysis:
• Pfizer Inc.
• Bristol-Myers Squibb Company
• Abbott Laboratories
• Amgen, Inc.
• Merck & Co., Inc.
• Novartis AG
• F. Hoffmann-La Roche Ltd
• Sanofi S.A.
• Qiagen NV
• Sun Pharmaceutical Industries Ltd…
Melanoma Diagnostics Market - Shining Light on Melanoma: Transforming Lives with …
Newark, New Castle, USA - new report, titled Melanoma Diagnostics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Melanoma Diagnostics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Melanoma Diagnostics market. The report offers an overview of the market, which…
Intraocular Melanoma Treatment Market Drivers
Neurological disorder diagnostics tools are medical devices, which are used in diagnosis of various neurological disorders such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and Multiple Sclerosis. The devices which are majorly used in diagnosis are imaging tools such as Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and in-vitro diagnostics tools such as biomarker and biopsy. Increasing prevalence of neurological disorders in the recent past has increased demand for diagnostic…
